• Richard Wonsettler was named VP of finance/CFO of Cohera Medical (Pittsburgh). Previously, Wonsettler was treasurer/CFO of Active Media/ClubCom. Cohera Medical makes wound management products and surgical adhesives.

• Michael Giuliani, MD, was named VP of R&D for pharmaceutical products and imaging solutions for Covidien (St. Louis). Dr. Giuliani comes to Covidien from Xanodyne Pharmaceuticals, where he was chief medical officer and executive VP of product development. Within the same division of Covidien, James Young, PhD, was named VP of R&D operations. Young previously was VP of product development at Xanodyne. Ralph Heasley, PhD, was named VP of global R&D technology, pharmaceutical products. Heasley also worked at Xanodyne. Covidien makes product lines in four segments: medical devices, imaging solutions, pharmaceutical products and medical supplies.

• Jos Lamers has been named CEO of Nucletron (Veenendaal, the Netherlands). Prior to joining Nucletron, Lamers held senior management and board positions at Numico. The appointment marks the next phase for the company following its successful management buy-out from Delft Instruments in August 2007, which created an independent company dedicated to radiation oncology.

• Tenet Healthcare (Dallas) reported that Dan Bowers was named CEO of John F. Kennedy Memorial Hospital, a 145-bed acute-care regional medical center located in Indio, California, east of Palm Springs. Bowers has been with Tenet since 1997, serving most recently as CEO of San Dimas Community Hospital. Tenet Healthcare, through its subsidiaries, owns and operates acute-care hospitals and related ancillary health care businesses, which include ambulatory surgery centers and diagnostic imaging centers.

• Dragan Nebrigic, PhD, has been promoted to VP of R&D at Thermage (Hayward, California). Nebrigic previously was senior director of advanced technologies, a position he assumed when he joined the company in August 2007. Thermage makes non-invasive tissue tightening products.